Patents Assigned to Aurelius Biotherapeutics, LLC
  • Patent number: 11648265
    Abstract: The present disclosure provides compositions of immune cells presenting a target molecule or a fragment thereof and provides compositions and methods of producing immune cell therapies with targeted activity against cancer. Methods for conditioning a subject receiving the immune cell therapy of the disclosure are additionally disclosed. The immune cell therapies of the present disclosure can be administered to a subject in need thereof for diseases such as cancer.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: May 16, 2023
    Assignee: Aurelius Biotherapeutics, LLC
    Inventors: Edmund Sullivan, Theresa Westfall